Bellicum Pharma (BLCM) Tops Q4 EPS by 8c
Bellicum Pharma (NASDAQ: BLCM) reported Q4 EPS of ($0.66), $0.08 better than the analyst estimate of ($0.74).
For earnings history and earnings-related data on Bellicum Pharma (BLCM) click here.
Bellicum Pharma (NASDAQ: BLCM) reported Q4 EPS of ($0.66), $0.08 better than the analyst estimate of ($0.74).
For earnings history and earnings-related data on Bellicum Pharma (BLCM) click here.